Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
May. 30, 2012—Yasmine S. Ali, assistant clinical professor of medicine, has been elected chair of the Tennessee Medical Association’s Young Physician Section and will serve as its representative to the TMA board. Jeffrey Conn, director of Vanderbilt’s Center for Neuroscience Drug Discovery, has won the first Tennessee Governor’s Award for Innovation Excellence for efforts to accelerate the...
May. 1, 2012—The May program for My Health Chat will be the fascinating field of neuroscience. Panelists will be Reid Thompson, chair of neurosurgery and director of the Vanderbilt Brain Tumor Center, and Jeff Conn, who directs the Vanderbilt Center for Neuroscience Drug Discovery. Topics will range from the latest innovative approaches in neurosurgery to the development...
Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.
Feb. 1, 2012—The Center for Technology Transfer and Commercialization is taking Vanderbilt researchers’ inventions to new heights Use the term “inventor,” and what pops to mind? The wild-haired Dr. Emmett Brown and his time-traveling DeLorean? The unflappable “Q” demonstrating a laser-enabled wristwatch or an exploding attaché case? Perhaps the Absent-Minded Professor and his gooey, green “flubber”? Hollywood...
Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.
Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.